ofloxacin has been researched along with oxytetracycline, anhydrous in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Arumainayagam, JT; Battu, V; McClean, AN | 1 |
| Lambert, R; Lambert, RJ | 1 |
| Altiparmak, UE; Aslan, BS; Duman, S; Ozer, PA; Ozkuyumcu, C; Us, AD | 1 |
| Liu, YS; Peng, FJ; Ying, GG; Zhao, JL; Zhou, LJ | 1 |
| Coradin, T; El Karbane, M; Gouza, A; Laghzizil, A; Laurent, G; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Chu, F; Dahlgren, RA; Du, L; Gu, H; Li, Y; Ma, Y; Wang, H; Wang, X; Zheng, Y | 1 |
| Chongsuvivatwong, V; McNeil, E; Sangthong, R; Tang, R; Xu, J | 1 |
| Bai, H; Chen, J; Gao, FZ; He, LX; He, LY; Hu, LX; Liu, YS; Yang, YY; Ying, GG; Zhao, JL | 1 |
| Guo, X; Huang, Y; Lam, SS; Liao, Q; Xia, A; Yao, D; Zhang, J; Zhu, X | 1 |
| Cai, C; Chen, R; Dai, X; Dong, B; Xiao, T; Xu, Z; Yuan, S | 1 |
1 review(s) available for ofloxacin and oxytetracycline, anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for ofloxacin and oxytetracycline, anhydrous
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Comparison of ofloxacin with oxytetracycline in the treatment of non-gonococcal urethritis in men.
Topics: Humans; Male; Ofloxacin; Oxytetracycline; Urethritis | 1991 |
A model for the efficacy of combined inhibitors.
Topics: Anti-Bacterial Agents; Ceftazidime; Choline; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Kanamycin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Oxytetracycline; Pseudomonas aeruginosa; Staphylococcus aureus; Surface-Active Agents; Thymol | 2003 |
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Bacillus cereus; Bacterial Typing Techniques; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluorescent Antibody Technique, Direct; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Middle Aged; Ofloxacin; Oxytetracycline; Phacoemulsification; Polymyxin B; Postoperative Complications; Vitreous Body | 2007 |
Antibacterial activity of the soil-bound antimicrobials oxytetracycline and ofloxacin.
Topics: Adsorption; Anti-Bacterial Agents; Escherichia coli; Ofloxacin; Oxytetracycline; Soil; Soil Pollutants | 2014 |
Oil shale powders and their interactions with ciprofloxacin, ofloxacin, and oxytetracycline antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Ciprofloxacin; Environmental Restoration and Remediation; Hydrophobic and Hydrophilic Interactions; Minerals; Morocco; Ofloxacin; Oxytetracycline; Powders; Soil Pollutants | 2017 |
Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following β-diketone antibiotic exposure to F0-zebrafish (Danio rerio).
Topics: Animals; Anti-Bacterial Agents; Atherosclerosis; Chlortetracycline; Cholesterol; Ciprofloxacin; Computational Biology; Disease Models, Animal; Doxycycline; Enrofloxacin; Female; Hyperlipidemias; Larva; Lipid Metabolism; Male; MicroRNAs; Ofloxacin; Oxytetracycline; Peroxisome Proliferator-Activated Receptors; Triglycerides; Up-Regulation; Zebrafish; Zebrafish Proteins | 2018 |
Antibiotic use in chicken farms in northwestern China.
Topics: Adult; Animals; Anti-Bacterial Agents; Ceftriaxone; Chickens; China; Cross-Sectional Studies; Drug Misuse; Farms; Female; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Logistic Models; Male; Middle Aged; Norfloxacin; Ofloxacin; One Health; Oxytetracycline; Socioeconomic Factors; Surveys and Questionnaires; Young Adult | 2020 |
The variations of antibiotics and antibiotic resistance genes in two subtropical large river basins of south China: Anthropogenic impacts and environmental risks.
Topics: Anthropogenic Effects; Anti-Bacterial Agents; China; Chlortetracycline; Drug Resistance, Microbial; Ecosystem; Enrofloxacin; Genes, Bacterial; Norfloxacin; Ofloxacin; Oxytetracycline; Rivers; RNA, Ribosomal, 16S; Sulfamethoxazole; Sulfonamides; Water | 2022 |
Removal of oxytetracycline and ofloxacin in wastewater by microalgae-bacteria symbiosis for bioenergy production.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Bacteria; Biomass; Carbohydrates; Chlorophyll; Microalgae; Nitrogen; Ofloxacin; Oxytetracycline; Phosphorus; Swine; Symbiosis; Wastewater | 2022 |
Abatement of antibiotics and resistance genes during catalytic ozonation enhanced sludge dewatering process: Synchronized in volume and hazardousness reduction.
Topics: Anti-Bacterial Agents; Bacteria; Genes, Bacterial; Norfloxacin; Ofloxacin; Oxytetracycline; Ozone; Sewage; Tetracycline | 2024 |